UPCOMING SESSIONS in ET
Tue, Sep 8, 2026
5:00 – 6:00 AM Bangkok
Your First Mayo Clinic Evaluation: What to Expect and How to Prepare Cecelia Hernandez Click Here To Register
UPCOMING SESSIONS in ET
Tue, Sep 8, 2026 · 5:00 – 6:00 AM Bangkok
Your First Mayo Clinic Evaluation: What to Expect and How to Prepare
Cecelia Hernandez
Click Here To Register
View all sessions

Transthyretin amyloidosis drug pipeline and IP landscape

Source
Patsnap

The ATTR amyloidosis pipeline has expanded far beyond patisiran, with RNA interference, CRISPR gene editing, monoclonal antibodies, and next-generation stabilizers all now represented in the patent record — and new entrants from Amgen and Chinese biotech intensifying the competitive landscape in 2025.